部分一作和通讯作者论文
(1)Zhang LQ, Liang YC, Wang JX, Zhang J, La T, Li QZ. Unlocking the potential: A novel prognostic index signature for acute myeloid leukemia. Comput Biol Med. (2024,top, IF=7.0)
(2)Zhang LQ, Hao YD, La T, Li QZ. Inferring the functional effect of gene-body H3K79me2 signals in normal samples on gene expression changes: A potential susceptibility marker in chronic myelogenous leukemia. Curr Bioinform. (2023, IF=4.0)
(3)Zhang LQ, Yang H, Liu JJ, Zhang LR, Hao YD, Guo JM, et al. Recognition of driver genes with potential prognostic implications in lung adenocarcinoma based on H3K79me2. Comput Struct Biotec. (2022, IF=6.155)
(4)Zhang LQ, Fan GL, Liu JJ, Liu L, Li QZ, Lin H. Identification of key histone modifications and their regulatory regions on gene expression level changes in chronic myelogenous leukemia. Front Cell Dev Biol. (2021, IF=6.081)
(5)Zhang LQ, Liu JJ, Liu L, Fan GL, Li YN, Li QZ. The impact of gene-body H3K36me3 patterns on gene expression level changes in chronic myelogenous leukemia. Gene. (2021, IF=3.9)
(6)Zhang LQ, Li QZ. Genome-wide analyses of histone modifications and their regulations to cancer-related genes expression in chronic myelogenous leukemia. Basic Clin Pharmacol. (2020, IF=4.084)
(7)Zhang LQ, Li QZ, Jin W, Zuo YC, Guo SC. Genome-wide analysis of H3K36me3 and its regulations to cancer-related genes expression in human cell lines. Biosystems. (2018, IF=2.0)
(8)Zhang LQ, Li QZ, Su WX, Jin W. Predicting gene expression level by the transcription factor binding signals in human embryonic stem cells, Biosystems. (2016, IF=2.0)
(9)Wang LY,Zhang LQ*, Li QZ. The risk model construction of the genes regulated by H3K36me3 and H3K79me2 in breast cancer. Biophysics Reports (2023, CSCD)